Dr Aston currently serves as Executive Chairman of PharmAust. Roger brings more than 20 years experience in the pharmaceutical and healthcare industries in senior roles in the UK, Asia Pacific and Australia. He has had extensive experience on boards and as Chief Executive Officer of many private and publically listed biotechnology companies. During his career, he has been closely involved in start-up companies and major pharmaceutical companies. Aspects of his experience include FDA and EU product registration, clinical trials, global licensing agreements, fundraising through private placements, and a network of contacts within the pharmaceutical, banking and stock broking sectors.
Dr Aston holds a B.Sc. (Hons) and Ph.D. degrees from the University of Manchester from 1975 to 1981.
Mr Robert Bishop (Executive Director) Robert has 30 years’ experience in corporate finance and equity capital markets.
Having worked extensively in London and Sydney, first as a lawyer at Linklaters & Paines and Allen, Allen & Hemsley; and then as a stockbroker and investment banker at Ord Minnett, Robert Fleming and, since 1998, at his Sydney based corporate finance business, First Capital Markets.
He has extensive experience in the areas of stock market flotation’s, licensing and compliance work.
Dr Best has over 35 years’ experience in organic chemistry and the biotechnology sector. He obtained his PhD in Organic Chemistry from the University of Western Australia. He then spent 2 years at Imperial College in the UK where he obtained a Diploma of the Imperial College (DIC), followed by a year at the Australian National University in Canberra. He then moved into the industry with a position at ICI Australia’s Research Group in Melbourne. Following ICI, Dr Best spent 10 years at the Chemistry Centre (WA) where he was responsible for the formation and running of the Medicinal & Biological Chemistry Section which undertook collaborative R&D into drug discovery and contract synthesis for the pharmaceutical industries.
In 2003, he founded Epichem Pty Ltd, a contract research company, where he is currently the Managing Director. Dr Best is also a Director of Epichem’s parent company, PharmAust Ltd. Dr Best is a Fellow of the Royal Australian Chemical Institute and an Adjunct Associate Professor of Chemistry at the University of Western Australia.
He is a Graduate Member of the Australian Institute of Company Directors and served as Chair of the WA Branch of the industry body AusBiotech for two years.
Sam Wright is experienced in the administration of ASX listed companies, corporate governance and corporate finance. He joined the Company as the Financial Controller in September 2006, was appointed as the Company Secretary in August 2007, and has been a Director of the Company since October 2008.
Mr Wright has over twenty years experience in the pharmaceutical, biotech and healthcare industry and is a member of the Australian Institute of Company Directors, the Financial Services Institute of Australasia, and the Chartered Secretaries of Australia. Mr Wright is currently Company Secretary of ASX listed companies, Buxton Resources Limited, Structural Monitoring Systems plc and Wide Open Agriculture Limited. Mr Wright also has filled the role of Director and Company Secretary with a number of unlisted companies.
He is the Managing Director of Perth-based corporate advisory firm Straight Lines Consultancy, specialising in the provision of corporate services to public companies.
Mr Wright has extensive experience in relation to public company responsibilities, including ASX and ASIC compliance, control and implementation of corporate governance, statutory financial reporting, and shareholder relations with both retail and institutional investors.